Trial intelligence / Profile preview

PGE1 in Cardiac Fibrosis and Angiogenesis During Pressure Overload

ChiCTR-OPC-17011136Phase 4Recruiting

Sponsor
The First Affiliated Hospital of Harbin Medical University
Start
Apr 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of Vasostenoon in heart failure (HF) and cardiac fibrosis (2 arms), sponsored by The First Affiliated Hospital of Harbin Medical University. Primary endpoint: Echocardiographic parameters. Started Apr 2017; status: recruiting.

02

Drugs

Vasostenoon
03

Conditions

heart failure (HF)cardiac fibrosis

Beyond the preview

Go deeper on ChiCTR-OPC-17011136.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-OPC-17011136.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call